Sirtuin

Estée Lauder Announces New Skin Longevity Initiative, The Next Frontier of Beauty

Retrieved on: 
Donnerstag, Dezember 14, 2023
Research, Luxury, Women, Specialty, Health Technology, Consumer, Health, Cosmetics, Retail, Science, Diamond, Life expectancy, Editorial, Norm (mathematics), Aesthetics, Senior, Assistant professor, Reproductive system, Creative, Congress, Human, Movement, Life, Ageing, Style Design College, Ultimate Diamond, Public policy, Weill Cornell Medicine, Beauty, University of California, Berkeley, Skin, University, Global Brands Group, Sirtuin, Murphy, Toxicology, Stanford University, International Chinese Language Program, Biology, Pharmaceutical industry, Management, Psychology, List of life sciences, Dermatology, Medicine, Longevity

Estée Lauder today announces its new Skin Longevity platform, grounded in 15-years of expertise in pioneering skin longevity research.

Key Points: 
  • Estée Lauder today announces its new Skin Longevity platform, grounded in 15-years of expertise in pioneering skin longevity research.
  • Estée Lauder also announces its support of the Stanford Center on Longevity and its new Program on Aesthetics & Culture, whose work will include research assessing perceptions on longevity and vitality.
  • “The Estée Lauder brand has always been at the forefront of breakthrough skin science,” said Justin Boxford, Global Brand President, Estée Lauder.
  • Building on the brand’s commitment to furthering longevity research, Estée Lauder announces its support of the Stanford Center on Longevity, a cross-disciplinary research center at Stanford University.

CCM Biosciences Announces Launch of Protein Upregulation Business Unit

Retrieved on: 
Mittwoch, September 20, 2023
Medicinal chemistry, National academy, SIRT1, University, Chemical physics, Mitochondrion, Bioorganic & Medicinal Chemistry, Enzyme, NAD, Mutation, RNA, Infertility, Cystic fibrosis, SIRT3, Alzheimer's disease, University of Palermo, Parkinson's disease, Protein, CCM, Publication, Journal, Patient, PLOS, Biophysics, Fertility, The Journal of Chemical Physics, Regulation, Cystic Fibrosis Foundation, Physics, Longevity, Notifiable disease, IND, Gene, Sirtuin, Library, Messenger, Dietary supplement, Pharmaceutical industry, Vaccine

MOUNT LAUREL, N.J., Sept. 20, 2023 /PRNewswire/ -- CCM Biosciences, a pharmaceutical discovery and development company that recently confirmed its launch from stealth, today announced its latest business unit — CCM Protein Upregulation — dedicated to advancing first-in-class drug leads for age-related conditions such as Alzheimer's, Parkinson's, and infertility as well as for genetically inherited diseases such as cystic fibrosis, using highly differentiated technology platforms for improving the enzymatic activity or expression level of critical proteins implicated in the pathogenesis of such disorders. 

Key Points: 
  • New business unit is focused on "undruggable" targets for age-related indications and genetically inherited diseases.
  • Enhancement of the activity or expression level of proteins is important for the treatment of many age-related and genetically inherited conditions.
  • Such compounds have the potential to rejuvenate the activity of SIRT3 to levels observed in youth," said Dr. Raj Chakrabarti, CEO of CCM Biosciences.
  • CCM Protein Upregulation's drug leads represent a first-in-class opportunity to treat multiple diseases caused by nonsense mutations.

The Estée Lauder Companies Shares New Preclinical and Clinical Findings at World Congress of Dermatology Spanning Emerging Research Areas that Support Skin Health and Longevity

Retrieved on: 
Donnerstag, Juli 6, 2023
Histology, La mer, Senior, Skin care, Xeroderma, SIRT2, 3D, Elastin, Clinical trial, Enzyme, EL, Ageing, Glycation, SIRT, AGE, Woman, Hyaluronic acid, Research, Sirtuin, Science, Thought, DE, Clinique, Congress, Parity, Beauty, Erythema, UV, ELC, Randomized controlled trial, Irritation, Hyperpigmentation, BrainScope Company, Inc., Advanced glycation end-product, Ozone, Knowledge, Poster, R, Longevity, Autostereogram, Human, NYSE, Identity matrix, Skin, N-Acetylglucosamine, Cosmetics, Medical imaging, Dietary supplement, Medical device, Dermatology

NEW YORK, July 6, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and several of its brands presented a range of novel preclinical and clinical findings at the 25th World Congress of Dermatology, held this week in Singapore. The poster and satellite symposium presentations reflect a strong portfolio of prestige beauty and skin care brands effectively translating biological learnings and progressive research efforts into meaningful innovation, including better methods to care for and protect skin.

Key Points: 
  • With rapidly emerging knowledge and advancements from the dermatologic and scientific communities, the science of skin care has never been more important," said Lisa Napolione, Senior Vice President, Global Research & Development (R&D).
  • "As we live longer, research on health span and longevity will only accelerate.
  • To meet these innovation challenges, we are thinking differently, and in a manner enabled by novel science across all our global laboratories and clinics."
  • Using 3D skin models, researchers studied the anti-glycation properties of 6 compounds to determine their capacities to reduce auto-fluorescence in 3D skin models.

The Estée Lauder Companies to Present Novel Scientific Data at World Congress of Dermatology

Retrieved on: 
Mittwoch, Juni 14, 2023
University, Senior, Sirtuin, Skin care, EL, Ageing, Longevity, Woman, Research, Toxicology, Inflammation, Doctor of Philosophy, Science, Chemistry, Congress, WCD, Publishing, Laboratory, ELC, University of California, Berkeley, Engineering, BrainScope Company, Inc., Physics, Biology, Poster, R, Science and technology in Asia, NYSE, Skin, Pharmaceutical industry, Cosmetics, List of life sciences, Dermatology

NEW YORK, June 14, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and its brands will present at the 25th World Congress of Dermatology (WCD) in Singapore from July 3-8, 2023. ELC researchers across 3 brands and ELC Research & Development (R&D) will share novel clinical and preclinical results that demonstrate scientific innovation and leadership across emerging areas of skin health and anti-aging in the form of 5 poster presentations and a satellite symposium during this global event, which takes place every 4 years.

Key Points: 
  • NEW YORK, June 14, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and its brands will present at the 25th World Congress of Dermatology (WCD) in Singapore from July 3-8, 2023.
  • "The breadth and depth of data to be presented further reflects our robust combined R&D and clinical testing capabilities.
  • These highly integrated areas of focus support our exploration of new ingredients or methodologies to ultimately help shape and advance the skin care landscape."
  • The company has 75 years of formulation authority and is deeply integrated into the scientific community, regularly presenting at leading events and publishing in peer-reviewed journals.

BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans

Retrieved on: 
Dienstag, April 18, 2023
STAC, Human, Texas A&M University, Horse, Stroke, Splenic infarction, Resveratrol, Doctor of Philosophy, Animal, Patent, LY, Sirtuin, Nonsteroidal anti-inflammatory drug, Research, Dietary supplement

LAS VEGAS, NV, April 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans.

Key Points: 
  • LAS VEGAS, NV, April 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans.
  • Edward Jacobs, M.D., CEO BioAdaptives, Inc., said, “We are very pleased to be extending our collaboration with Dr. Yaguang Liu, LY Research through this non-exclusive licensing agreement bringing this breakthrough supplement to the market.
  • Resveratrol offers an array of health benefits as a result of its anti-inflammatory and antioxidant properties that can benefit both animals and humans.
  • “This implies that resveratrol may be a useful adjunct therapy in horses with joint problems and a good alternative to nonsteroidal anti-inflammatory drugs (NSAIDs).

LifeQ Study, Published in bioRxiv, Finds Wearables Measure Biological Aging

Retrieved on: 
Montag, April 17, 2023
Acceleration, Exercise, Insurance, DNA, Human, Methylation, TAG Heuer, Electronics, AMPK, Calendar, Sleep, Ageing, Foot, Physiology, Samsung, Infection, Biomarker, Life expectancy, Fossil Group, Illumina, Motorola, Nature, Sanitation, PPG, Blood, Biology, Montblanc, DNA methylation, Health, Gene, Life, Behavior, Genome, Conditional sentence, Vaccine, Medical imaging, Suunto, Hublot, Sirtuin, Photoplethysmogram

ATLANTA, April 17, 2023 /PRNewswire/ -- LifeQ, the company that uses globally-recognized watch brands to gather personalized, clinical-grade data, announced the results of its groundbreaking new study—Wearable-ome meets epigenome: A novel approach to measuring biological age with wearable devices, published in bioRxiv—revealing clear associations between wearable-derived behavioral and physiological features and the methylation of specific genes in pathways relating to the aging process.

Key Points: 
  • Wearable devices offer a non-invasive, continuous measure of physiological and behavioral features and how they pertain to aging."
  • For the LifeQ study, LifeQ-enabled wearables were used to measure behavior and its impacted physiological states, and DNA methylation levels were determined using the Illumina EPIC array.
  • "Biological aging is driven by epigenetic changes which can be measured by blood and DNA analysis," stated Dr. Deffur.
  • LifeQ-enabled wearables may also monitor and quantify various physiological biomarkers that correlate with life expectancy and the rate of biological aging.

TOP HEALTH NEWS: Better Aging May Soon Be Just A Pill Away

Retrieved on: 
Mittwoch, März 15, 2023
Research, Radiation, Cancer, Harvard University, Longevity, Deficit spending, DNA, NAD, Ageing, Mouse, Cell, Water, Cellular senescence, Brain, Fountain of Youth, Younes Chaib, Old age, Computer mathematics, Science, Health, Sirtuin, Inflammation, SA, SSA, Fisetin, Nature Medicine, PMID, DNA repair, Nervous system, Scripps Research, DNA replication, Mayo Clinic, Oxidative stress, Vaccine, Amusement park, Hospital, Brightwell

IRVINE, Calif., March 14, 2023 /PRNewswire-PRWeb/ -- Regardless of whether the age-old myth of explorer Ponce de Leon searching for a Fountain of Youth is true, a new nutraceutical reaching the consumer market will mark a major milestone in the expedition towards improving the process of aging.

Key Points: 
  • Researchers at Irvine, California-based Seragon Biosciences have developed a proprietary set of molecules that have been found to slow aging and issues that arise with aging.
  • When integrated with a new controlled release technology, this new nutraceutical RESTORIN can attack the aging process at the cellular level.
  • Other studies have shown that using senolytics to reduce oxidative stress and cellular senescence in the brain can improve brain health.
  • "It's very thrilling to see aging research advancing ways to help people age slower, better, and healthier," he added.

Introducing SirtLife Nutrition™ - The Revolutionary Supplement Brand That Is A Powerful Extension of The Proven Sirtfood Diet

Retrieved on: 
Donnerstag, Februar 2, 2023
Diet, Sirtuin-activating compound, Pharmacology, Antioxidant, Duke, Polyphenol, Metabolism, Digestion, Ageing, Health, UFC, Fad diet, Sirte, Sirtuin, Prince Harry, Duke of Sussex, LOS, Dietary supplement, BRIT

LOS ANGELES, Feb. 2, 2023 /PRNewswire/ -- Introducing SirtLife Nutrition™, a revolutionary supplement brand and extension of the popular Sirtfood Diet, founded by experts in nutritional medicine and pharmacology, Aidan Goggins and Glen Matten. The Sirtfood diet is based on the scientific principle that foods rich in polyphenols help activate the body's "skinny gene" – aka sirtuins. As sirtuins—a family of signaling proteins involved in metabolic regulation— are activated in the body, this natural protein supports a metabolic boost to support healthy aging and a stronger, healthier body. SirtLife Nutrition harnesses these principles into their cutting-edge formulas to serve as an extension of the Sirtfood Diet and help you boost your metabolism for a slimmer physique.†*

Key Points: 
  • SirtLife Nutrition Provides Convenient, Science-Backed Solutions to Help Users Achieve a Slimmer, Healthier Body
    LOS ANGELES, Feb. 2, 2023 /PRNewswire/ -- Introducing SirtLife Nutrition™ , a revolutionary supplement brand and extension of the popular Sirtfood Diet , founded by experts in nutritional medicine and pharmacology, Aidan Goggins and Glen Matten.
  • The Sirtfood diet is based on the scientific principle that foods rich in polyphenols help activate the body's "skinny gene" – aka sirtuins.
  • Pharmacist Aidan Goggins and nutritionist Glen Matten received global success with their international bestselling book "The Sirtfood Diet."
  • Ultimate Sirt Juice also contains antioxidants to support cardiovascular and immune health, and improve your sense of overall wellness as you age.

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

Retrieved on: 
Donnerstag, Januar 19, 2023
Neurodegeneration, Cell, Ageing, Journal of the ACM, Longevity, DNA, Harvard University, Mayo Clinic, NAD, Sirtuin, Protein, Diabetes, Research, Cancer, Scripps Research, Science, Vaccine

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.

Key Points: 
  • IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.
  • For decades, the intricate nature of aging has left scientists with many stones unturned in the field of aging intervention.
  • The latest research has pinpointed senolytics and NAD+ as key technologies to address this challenge.
  • "We've been able to develop advanced forms of these molecules and a series of complex combinations to combat aging, using the best science we have.

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

Retrieved on: 
Donnerstag, Januar 19, 2023
Neurodegeneration, Cell, Ageing, Journal of the ACM, Longevity, DNA, Harvard University, Mayo Clinic, NAD, Sirtuin, Protein, Diabetes, Research, Cancer, Scripps Research, Science, Vaccine

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.

Key Points: 
  • IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.
  • For decades, the intricate nature of aging has left scientists with many stones unturned in the field of aging intervention.
  • The latest research has pinpointed senolytics and NAD+ as key technologies to address this challenge.
  • "We've been able to develop advanced forms of these molecules and a series of complex combinations to combat aging, using the best science we have.